Executive Track
Jeanne Hecht, MBA, PMP (she/her/hers)
Founder and CEO
JTH Consulting & Associates
Chapel Hill, North Carolina
Gerald Finken, R.Ph., M.S. (he/him/his)
CEO
RxE2 Inc.
Fargo, North Dakota
This executive track session will debate the potential business and clinical value of integrating clinical research into the overall continuum of care, while exploring the potential stated (and suggested) impacts on global health, access to health care, and imperative need for studies to generate timely reliable clinical evidence to illustrate significance. Today, less than 1% of the U.S. population participates in clinical trials, yet 72% say they would participate if recommended to do so by their doctor. Could this model be an answer? What else needs to be considered?
What are the advantages and disadvantages of this model for all stakeholders? What are the key concerns researchers, patients, and others need to consider when looking at this emerging model?
7:00am: Breakfast
7:30am: Presentation